Aerovate Therapeutics Bolsa (NASDAQ: AVTE)

Aerovate Therapeutics (NASDAQ:AVTE) Bolsa

Aerovate Therapeutics

Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. The initial focus of the company is on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension.

Aerovate Therapeutics, Inc. - Common Stock

Aerovate Therapeutics Inc

Maxim Group analyst Matthew Galinko downgrades Arbe Robotics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARBE#NASDAQ">ARBE</a>) from Buy to Hold.

News

Downgrades

Analyst Ratings

ARBE

Maxim Group Downgrades Arbe Robotics to Hold

Lake Street analyst Frank Takkinen maintains Sight Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGHT#NASDAQ">SGHT</a>) with a Hold and lowers the price target from $3 to $2.5.

Price Target

SGHT

Lake Street Maintains Hold on Sight Sciences, Lowers Price Target to $2.5

Lake Street analyst Jacob Stephan maintains CompoSecure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPO#NASDAQ">CMPO</a>) with a Buy and lowers the price target from $18 to $15.

CMPO

Lake Street Maintains Buy on CompoSecure, Lowers Price Target to $15

Lake Street analyst Jaeson Schmidt maintains Identiv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INVE#NASDAQ">INVE</a>) with a Buy and lowers the price target from $7 to $6.

INVE

Lake Street Maintains Buy on Identiv, Lowers Price Target to $6

The Ordinary Shares are expected to begin trading on the NYSE American under the ticker symbol "MCRP" on March 7, 2025. The Offering is expected to close on March 10, 2025, subject to satisfaction of customary closing conditions.

IPOs

MCRP

Micropolis Prices IPO Of 3.875M Ordinary Shares At $4.00 Per Share; To Begin Trading On NYSE American Under Ticker Symbol 'MCRP' On March 7

Jefferies analyst Anthony Petrone maintains Tarsus Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TARS#NASDAQ">TARS</a>) with a Buy and raises the price target from $54 to $58.

TARS

Jefferies Maintains Buy on Tarsus Pharmaceuticals, Raises Price Target to $58

The CFPB's dismissal follows its multi-year investigation which began prior to Upbound's acquisition of Acima in 2021. Acima will not pay any money, be required to change any business practices, or be subject to any injunctive or other relief, and the dismissal with prejudice ends the CFPB's challenge to the alleged business practices that were the subject of its investigation and lawsuit.
In connection with the CFPB's determination to drop its claims against Acima, Acima has agreed to dismiss the lawsuit it filed against the CFPB in the United States District Court for the Eastern District of Texas, which challenged the CFPB's authority to pursue those claims against Acima.

Legal

UPBD

Upbound Says Consumer Financial Protection Bureau Has Voluntarily Dismissed Lawsuit Against Its Unit Acima Leasing

Jones Trading analyst Matthew Erdner maintains Real Brokerage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REAX#NASDAQ">REAX</a>) with a Buy and maintains $6 price target.

REAX

Jones Trading Maintains Buy on Real Brokerage, Maintains $6 Price Target

Scotiabank analyst Patrick Colville maintains Zscaler (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZS#NASDAQ">ZS</a>) with a Sector Outperform and raises the price target from $225 to $242.

Scotiabank Maintains Sector Outperform on Zscaler, Raises Price Target to $242

DXP Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXPE#NASDAQ">DXPE</a>) reported quarterly earnings of $1.38 per share which beat the analyst consensus estimate of $0.89 by 55.06 percent. This is a 23.21 percent increase over earnings of $1.12 per share from the same period last year. The company reported quarterly sales of $470.91 million which beat the analyst consensus estimate of $447.00 million by 5.35 percent. This is a 15.69 percent increase over sales of $407.04 million the same period last year.

Earnings

Earnings Beats

DXPE

DXP Enterprises Q4 2024 Adj EPS $1.38 Beats $0.89 Estimate, Sales $470.91M Beat $447.00M Estimate

Trading Halt: Halt status updated at 5:40:00 PM ET: Quotation Resumption: News and Resumption Times

Scotiabank analyst Brandon Bingham maintains Williams Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMB#NYSE">WMB</a>) with a Sector Perform and raises the price target from $51 to $53.

Scotiabank Maintains Sector Perform on Williams Companies, Raises Price Target to $53

Scotiabank analyst Nicholas Yulico maintains Welltower (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WELL#NYSE">WELL</a>) with a Sector Outperform and raises the price target from $165 to $166.

WELL

Scotiabank Maintains Sector Outperform on Welltower, Raises Price Target to $166

Scotiabank analyst Allan Verkhovski maintains Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) with a Sector Perform and raises the price target from $240 to $245.

VEEV

Scotiabank Maintains Sector Perform on Veeva Systems, Raises Price Target to $245

Editor&#8217;s Note: This article has been updated to include a statement from Zelle.
The Consumer Financial Protection Bureau <a href="https://www.benzinga.com/news/legal/24/12/42687945/zelle-became-a-gold-mine-for-fraudsters-consumer-financial-protection-bureau-lawsuit">dropped its lawsuit</a> against JPMorgan Chase &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>), Wells Fargo &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>) and Bank of America Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) on Tuesday concerning the banks&#8217; alleged failure to prevent fraud on Zelle. The Trump Administration has <a href="https://www.benzinga.com/news/25/02/44028664/trump-says-he-shut-down-the-ultra-left-cfpb-after-bankers-and-loan-officers-called-him-almost-crying">wound down CFPB cases</a> in recent weeks.
What Happened: The agency dismissed its case against the banks and Early Warning Services, Zelle&#8217;s parent company, CNBC <a href="https://www.cnbc.com/2025/03/04/cfpb-drops-jpmorgan-bank-of-america-wells-fargo-lawsuit.html">reports</a>. The lawsuit was originally brought in December during the Biden Administration.
The lawsuit alleged that banks did not do enough to protect and reimburse consumers from fraud on Zelle. The defendants allegedly rushed to launch Zelle without implementing sufficient anti-fraud protections. Because the cases were dismissed with prejudice, the agency will not bring similar charges against the banks again.
A Zelle spokesperson said, "We welcome the CFPB's decision to drop its lawsuit against the Zelle network. As we've said before, this lawsuit was without merit and legally and factually flawed. We look forward to continuing to provide Zelle, a trusted service, to 151 million enrolled American consumer and small business accounts."
The CFPB&#8217;s December <a href="https://files.consumerfinance.gov/f/documents/cfpb_Zelle-Complaint_2024-12.pdf">filing</a> said that 210,000 Bank of America customers experienced over $290 million in collective losses, 420,000 Chase customers lost over $360 million and 280,000 Wells Fargo customers were defrauded of over $220 million since 2017.
Reactions: The Trump administration has ended several consumer protection cases in recent weeks. Elon Musk, senior advisor to Trump, previously <a href="https://x.com/elonmusk/status/1861644897490751865">said</a> he&#8217;d like to &#8220;delete&#8221; the CFPB.
The CFPB&#8217;s <a href="https://www.consumerfinance.gov/about-us/the-bureau/" target="_blank" rel="noopener">mission</a> is to &#8220;protect consumers from unfair, deceptive, or abusive practices and take action against companies that break the law.&#8221;
Political figures reacted to the cases dropped by the agency.
&#8220;The CFPB makes up just 0.01% of the federal budget, yet it has returned $21 BILLION to American taxpayers,&#8221; Congressman Bill Foster (D-IL) <a href="https://x.com/RepBillFoster/status/1896672481190023622">said</a>. &#8220;Still, Trump &amp; Musk want to shut it down and make it easier for scammers to rip you off.&#8221;
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/03/44110273/trump-tariffs-will-raise-prices-within-days-target-ceo-says">Trump Tariffs Will Raise Prices &#8216;Within Days,&#8217; Target CEO Says</a></li>
</ul>
Photo: Shutterstock

Equities

Government

CFPB Drops Zelle Fraud Reimbursement Case Against JPMorgan, Wells Fargo (UPDATED)

"We made significant progress in February across every layer of our platform, from expanding our footprint to developing digital infrastructure and upgrading our ASIC fleet," said Asher Genoot, CEO of Hut 8.

Hut 8 February 2025 Bitcoin Produced 46 BTC Vs. 65 BTC In January 2025

Teledyne Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDY#NYSE">TDY</a>) has outperformed the market over the past 15 years by 6.66% on an annualized basis producing an average annual return of 17.93%. Currently, Teledyne Technologies has a market capitalization of $23.01 billion. 
Buying $1000 In TDY: If an investor had bought $1000 of TDY stock 15 years ago, it would be worth $11,860.70 today based on a price of $491.27 for TDY at the time of writing.
<h3>Teledyne Technologies's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741300224_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much You Would Have Made Owning Teledyne Technologies Stock In The Last 15 Years

Scotiabank analyst Brandon Bingham maintains Targa Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRGP#NYSE">TRGP</a>) with a Sector Outperform and lowers the price target from $218 to $210.

TRGP

Scotiabank Maintains Sector Outperform on Targa Resources, Lowers Price Target to $210

Intuitive Machines Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNR#NASDAQ">LUNR</a>) shares are extending losses from the regular session in after-hours Thursday after the company&#8217;s moon lander experienced technical issues during its <a href="https://www.benzinga.com/25/03/44176176/intuitive-machines-stock-falls-after-uncertain-athena-moon-landing-what-you-need-to-know">attempted moon landing</a>.
What Happened: Intuitive Machines shares fell more than 20% on Thursday after the company&#8217;s IM-2 mission Nova-C class lunar lander "Athena" experienced some issues around the time it was scheduled to touch down on the moon&#8217;s surface.
The selloff in shares accelerated after the market close as the company and NASA held a press conference to provide updates on the IM-2 mission.
&#8220;We&#8217;ve been very successful to this point, however I do have to tell you that we don&#8217;t believe we&#8217;re in the correct attitude on the surface of the moon yet again,&#8221; Intuitive Machines CEO Steve Altemus said in the press conference.
The Intuitive Machines IM-2 mission is the company&#8217;s second under NASA&#8217;s Commercial Lunar Payload Services initiative, which aims to lay the foundation for future human missions and a long-term human presence on the moon. The company&#8217;s moon lander "Odysseus" landed on the moon's surface last year, but was incorrectly positioned.
Altemus noted that communications are working properly on the moon lander, but there are issues with power generation and challenges with measurements from the laser range finders&nbsp;on the lander, which likely means that it&#8217;s laying on its side.
Intuitive Machines said it will provide further updates once it can confirm the position of the lander. The company plans to evaluate mission plans with NASA as more data becomes available.
LUNR Price Action: At the time of publication, <a href="http://benzinga.com/quote/lunr" target="_blank" rel="noreferrer noopener">Intuitive Machines shares</a> were down 25.22% after hours at $8.42 after falling more than 20% in the regular session, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/space/25/03/44158838/elon-musks-spacex-starships-next-test-flight-further-postponed-to-thursday">Elon Musk&#8217;s SpaceX Starship&#8217;s Next Test Flight Further Postponed To Thursday</a></li>
</ul>
Photo: Courtesy of Intuitive Machines.

SPACE

Movers

LUNR

Intuitive Machines Stock Is In Free Fall Thursday: What's Going On?

Scotiabank analyst Brandon Bingham maintains Plains All American (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAA#NASDAQ">PAA</a>) with a Sector Outperform and lowers the price target from $23 to $22.

Comments

Aerovate Therapeutics

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL